Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension

NCT05951166 is registered in ClinicalTrials.gov with Gradient Denervation Technologies as lead sponsor.

NCT NCT05951166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05951166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension
Lead sponsor
Gradient Denervation Technologies
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 5, 2023
Completion date
July 1, 2025
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure patients with pulmonary hypertension